Labcorp Inc.
LH | NYSE
$320.99
+$0.28 (+0.09%)
At close: Sep 21, 2026, 4:00 PM ET
$302.99
-$18 (-5.61%)
Pre-market:
Sep 22, 2026, 8:19 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B | 13.98B |
Cost of Revenue | 10.22B | 9.38B | 8.8B | 8.16B | 8.14B | 9.03B |
Gross Profit | 3.73B | 3.62B | 3.36B | 3.71B | 4.99B | 4.95B |
Operating Income | 1.52B | 1.09B | 725.6M | 1.44B | 3.05B | 2.45B |
Interest Income | 15.2M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.11B | 959.5M | 568.9M | 1.24B | 2.89B | 2.22B |
Net Income | 876.5M | 746M | 418M | 1.28B | 2.38B | 1.56B |
Selling & General & Admin | 2.22B | 2.23B | 2.02B | 2B | 1.69B | 1.73B |
Research & Development | n/a | n/a | 2M | n/a | n/a | n/a |
Other Expenses | n/a | 307.7M | 615.9M | 275.8M | 253.5M | 778.1M |
Operating Expenses | 2.22B | 2.54B | 2.64B | 2.27B | 1.94B | 2.51B |
Interest Expense | 224.1M | 208.3M | 199.6M | 179.8M | 211.8M | 207.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.44B | 11.92B | 11.44B | 10.43B | 10.09B | 11.53B |
Income Tax Expense | 229.8M | 212.4M | 188.5M | 233.9M | 690M | 662.1M |
Shares Outstanding (Basic) | 83.2M | 83.9M | 87.1M | 91.1M | 96.7M | 97.3M |
Shares Outstanding (Diluted) | 83.8M | 84.4M | 87.6M | 91.6M | 97.5M | 98M |
EPS (Basic) | 10.54 | 8.89 | 4.80 | 14.04 | 24.58 | 15.99 |
EPS (Diluted) | 10.46 | 8.84 | 4.77 | 13.96 | 24.38 | 15.88 |
EBITDA | 2.01B | 1.81B | 1.35B | 1.95B | 3.68B | 3.25B |
EBIT | 1.33B | 1.17B | 768.5M | 1.42B | 3.1B | 2.43B |
Depreciation & Amortization | 681.1M | 643.5M | 577.3M | 537.2M | 577M | 825M |
Add to Watchlist
Select watchlists to add or remove LH